Trade Summary

4 days ago, Kuriakose Emil, serving as Chief Medical Officer at Terns Pharmaceuticals, Inc. (TERN), sold 942 shares at $52.75 per share, for a total transaction value of $49,693.00. Following this transaction, Kuriakose Emil now holds 105,673 shares of TERN.

This sale represents a 1.00% decrease in Kuriakose Emil's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, April 1, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, April 2, 2026, 1 day after the trade was made.

Terns Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.